NCT05567536Active, not recruiting
Long Term Follow-up of Comparison of Clopidogrel vs. Aspirin Monotherapy After Drug-eluting Stent Implantation
HOST-EXAM-Ex : Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - EXtended Antiplatelet Monotherapy - EXtended Follow up
Source: ClinicalTrials.gov · Last updated 5 Oct 2022
Brief summary (registry, in English)
This is an retrospective extended study of a randomized clinical trial (The HOST-EXAM trial ClinicalTrials.gov Identifier: NCT02044250). Investigators will perform a retrospective analysis of all participants enrolled in this trial will be performed, until the longest follow-up duration.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 5530 (actual)
- First submitted
- 26 Sept 2022
- Start date
- 1 Mar 2014
- Primary completion date
- 1 Oct 2022
- Lead sponsor
- Seoul National University Hospital
- Diseases
- Coronary artery disease
- NCT number
- NCT05567536
What you commit to
- Study type: Observational
- Participants enrolled: 5530
- From 1 Mar 2014 to the primary completion date, 1 Oct 2022
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None, otherwise the patient refuses to participate in this study, or refuses to provide personal medical information
Who the study is looking for
- Patients who were enrolled in the HOST-EXAM randomized clinical trial
Age in the registry: 19 years to - · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.